Brain Gut Axis Changes After Bariatric Surgery and Their Relationship to Weight Loss
NCT ID: NCT04429386
Last Updated: 2021-08-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
22 participants
OBSERVATIONAL
2014-02-15
2021-04-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Obese women undergoing weight loss surgery will be recruited to participate in the study. These individuals will undergo a screening visit and 4 study visits. The study visits will occur before, and at 1-, 6- and 12 months after the weight loss surgery. Each study visit will include evaluation of brain function (fMRI), anthropometrics, blood and stool samples and eating behaviors questionnaires.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Role of Dietary Habits in Efficacy of Bariatric Surgery - Study C
NCT03482986
Neural Response to Eating and Weight Status
NCT01228097
Microbiome and Bariatric Surgery
NCT03065426
Eating Behavior and Weight Trajectory After Bariatric Surgery
NCT04526743
Outcome of Bariatric Surgery in Patients With BMI Greater Than 60 .
NCT04663425
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Obese women undergoing weight loss surgery will be recruited to participate in the study. These subjects will undergo a screening visit and 4 study visits. The study visits will occur before, and at 1-, 6- and 12 months after the weight loss surgery. Each study visit will include evaluation of brain function (fMRI), anthropometrics, blood samples (gut hormones, cytokines, metabolomics ) and stool samples (16S RNA and Metabolomics) and eating behaviors questionnaires (YFAS, TFEQ, food cravings/preferences scales, 3-day food food intake records)
Primary outcomes: weight loss after surgery and changes in eating behaviors scales (YFAS, TFEQ) , metabolomics, appetite related hormones and gut microbiome (16S RNA) Secondary outcomes: changes in brain function (fMRI/MRS), diet (3-day food intake records) and inflammatory markers.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Bariatric surgery
Laparoscopic bariatric surgery including gastric bypass and sleeve gastrectomy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Eligible and approved for undergoing laparoscopic gastric bypass (LRYGB) or laparoscopic sleeve gastrectomy (LSG) following the Guidelines for Clinical application of Laparoscopic Bariatric Surgery by of American Gastrointestinal and Endoscopic Surgeons (SAGES)
* Right-handed
Exclusion Criteria
* Use of medications known to affect hunger, satiety, or intestinal motility.
* Unwillingness or inability to give informed consent
* Any contraindication to undergo MRI
* Current or past alcohol or drug abuse problem or smoking
* Pregnancy, lactating or post partum less than 12 months
* Body weight at enrollment greater than 350 lbs.
* Current use of insulin and or insulin dependent diabetes
* Renal insufficiency, retinopathy, or neuropathy.
* Post menopausal (defined as no menses for 12 consecutive months)
18 Years
55 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of California, Los Angeles
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB#13-001552
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.